Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Lotus Pharmaceutical Co., Ltd. (1795:TWSE), powered by AI.
Lotus Pharmaceutical Co., Ltd. is currently trading at $193.50. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Lotus Pharmaceutical Co., Ltd. on Alpha Lenz.
View Lotus Pharmaceutical Co., Ltd.'s valuation metrics on Alpha Lenz.
“Lotus Pharmaceutical Co., Ltd.'s ROE is 21.0%. Explore profitability and growth together.”
Ask for details →Lotus Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the development, manufacture, and sale of a wide range of healthcare products. Its primary function is to produce generic and specialty pharmaceuticals that cater to the healthcare needs across various therapeutic areas. Lotus Pharmaceutical focuses on delivering high-quality and affordable medication solutions, positioning itself as a key provider in both domestic and international markets. The company operates within the dynamic pharmaceutical sector, impacting industries such as health and wellness, biotechnology, and medical research. With a commitment to innovative drug development and strategic partnerships, Lotus Pharmaceutical plays a vital role in improving patient outcomes and expanding access to essential medications worldwide. Founded with a mission to address diverse medical needs, the company sustains its growth through robust research and development efforts and a broad manufacturing and distribution network. As a significant player in the pharmaceutical landscape, Lotus Pharmaceutical Co., Ltd. contributes notably to global healthcare advancements.
“Lotus Pharmaceutical Co., Ltd.'s ROE is 21.0%. Explore profitability and growth together.”
Ask for details →Lotus Pharmaceutical Co., Ltd. (ticker: 1795) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
The current price is 193.5 with a P/E ratio of -x and P/B of -x.
ROE is 21.00% and operating margin is 28.75%. Annual revenue is $20.5B.